Efg Asset Management (North America) Corp. Horizon Therapeutics Public LTD CO Transaction History

Efg Asset Management (North America) Corp.

  • $585 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$62.39 - $113.8 $4.21 Million - $7.67 Million
-67,415 Reduced 72.11%
26,070 $2.97 Million
Q3 2022

Oct 28, 2022
BUY
$58.92 - $84.67 $98,691 - $141,822
1,675 Added 1.82%
93,485 $5.79 Million
Q2 2022

Aug 04, 2022
SELL
$79.4 - $116.36 $324,666 - $475,796
-4,089 Reduced 4.26%
91,810 $7.33 Million
Q1 2022

Apr 26, 2022
BUY
$86.42 - $109.81 $8.29 Million - $10.5 Million
95,899 New
95,899 $10.1 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email